Chapple_foreword.qxp 26/2/08 11:21 am Page 6
Christopher R Chapple
Adjunct Secretary General, European Association of Urology (EAU)
Christopher R Chapple is Adjunct Secretary General of the European Association of Urology (EAU). He is also a Consultant Urological Surgeon
at the Royal Hallamshire Hospital and a Visiting Professor of Urology at Sheffield Hallam University. Professor Chapple is an active member of
the American Association of Genito-urinary Surgeons (AAGUS), the European Association of Academic Urologists (EAAU) and the Urological
Research Society (URS). He is Editor of Neurourology and Urodynamics, is on the Editorial Board of several journals and has published over
250 papers in peer-reviewed journals and written and edited several book. He is Past Director of Research at the Sheffield Teaching Hospitals
NHS Trust. Professor Chapple trained at the Middlesex Hospital and Institute of Urology in London.
elcome to the fifth edition of European Genito-urinary Disease. Once again, this informative publication features
a series of articles that discuss and review many important issues relevant to urologists throughout Europe and,
indeed, the world. This update reviews the field of genito-urinary disease and emphasises the large number of
developments occurring in all disease areas within the field. It emphasises both the wide spectrum of medical and surgical
topics that are encompassed by the speciality of urology, and the pivotal role played by urologists within this disease area.
Collaboration with colleagues in gynaecology, infectious diseases and oncology is essential to provide the best quality of care
to our patients. The European Association of Urology (EAU) has developed an extensive and comprehensive programme of
educational and scientific activities relating to all of these important disease areas. The EAU annual meeting in March 2008
will be the largest meeting to date and will be the main European and international forum where the latest advances in the
field of urology will be reviewed in detail. The second European multidisciplinary meeting on urological cancers will be held
in November 2008 in collaboration with our colleagues in medical oncology and radiation therapy. EAU-organised teaching
courses, masterclasses and consensus meetings in all of the topics outlined in this update are also going to be held in 2008.
New EAU initiatives worthy of note are network training in female and functional urology and a multidisciplinary update
meeting in andrology focusing on erectile dysfunction, the metabolic syndrome and hormonal therapy.
This edition of European Genito-urinary Disease opens with features on the management of prostate disease, beginning with
an update on both traditional electrosurgery and laser therapy for benign prostatic hyperplasia, then moves on to prostate
cancer. There is expert discussion on topics as varied as advances in diagnostic markers for cancer, advances in the
management of prostate cancer and the issue of the management of recurrent prostate cancer. Both the current guidelines
for the management of bladder cancer and the appropriate surgical approach for the management of upper tract urothelial
cell carcinoma are also tackled in this edition.
Evidencing the important area of functional urology, there is a review on the role of buccal mucosa in urethroplasty. A
comprehensive feature containing three articles on urogynaecology follows this, covering the important areas of pelvic
inflammatory disease, trichomonas vaginalis and pelvic organ prolapse and the associated urinary incontinence. The
management of overactive bladder, relating to pharmacology both now and in the future, and the interesting areas of
neuromodulation, urinary tract infections, male infertility and priapism complete the content for this edition, and the
informative articles provide valuable insights into and expert summary of the current developments within these areas
European Genito-urinary Disease would like to thank everyone involved for successfully providing interesting and informative
expert discussion on a variety of urological disorders and diseases that warrant our debate, time and attention. We would like
to thank the organisations and media partners for their continued support, and also say a big thank you to the individual
authors for their time and effort, which has resulted in a selection of excellent articles. We trust you will find this edition an
informative and enjoyable read. ■
6 © TOUCH BRIEFINGS 2007